DS\u00d6, \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinde kullan\u0131lan temel ila\u00e7lar\u0131n \u00e7ocuklara uygun form\u00fclasyonlar\u0131n\u0131n geli\u015ftirilmesi amac\u0131yla alt\u0131 yeni hedef \u00fcr\u00fcn profili (TPP) yay\u0131mlad\u0131.<\/p>\n
DS\u00d6 verilerine g\u00f6re her y\u0131l yakla\u015f\u0131k 400 bin \u00e7ocuk ve ergen kansere yakalan\u0131yor. D\u00fc\u015f\u00fck ve orta gelirli \u00fclkelerde \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinde hayatta kalma oranlar\u0131n\u0131n y\u00fczde 30\u2019un alt\u0131nda kald\u0131\u011f\u0131, y\u00fcksek gelirli \u00fclkelerde ise bu oran\u0131n y\u00fczde 80\u2019in \u00fczerine \u00e7\u0131kt\u0131\u011f\u0131 belirtildi.<\/p>\n
A\u00e7\u0131klamada, ya\u015fa uygun ila\u00e7lar\u0131n bulunmamas\u0131n\u0131n tedavide \u00f6nemli bir engel olu\u015fturdu\u011fu ifade edildi. \u00c7ocuklar\u0131n s\u0131kl\u0131kla yeti\u015fkinlere y\u00f6nelik form\u00fclasyonlar\u0131 kullanmak zorunda kald\u0131\u011f\u0131, bu ila\u00e7lar\u0131n uygulanmas\u0131n\u0131n g\u00fc\u00e7 olmas\u0131 nedeniyle dozlama hatalar\u0131 ve tedaviye ili\u015fkin risklerin ortaya \u00e7\u0131kabildi\u011fi kaydedildi.<\/p>\n
DS\u00d6 taraf\u0131ndan haz\u0131rlanan hedef \u00fcr\u00fcn profilleri; siklofosfamid, etoposid, merkaptop\u00fcrin, metotreksat, prokarbazin ve temozolomid olmak \u00fczere alt\u0131 kanser ilac\u0131n\u0131n \u00e7ocuklara uygun yeni form\u00fclasyonlar\u0131 i\u00e7in asgari ve ideal standartlar\u0131 belirliyor.<\/p>\n
Profillerin, DS\u00d6’n\u00fcn \u00c7ocuklara Y\u00f6nelik Form\u00fclasyonlar K\u00fcresel H\u0131zland\u0131rma A\u011f\u0131 (GAP-f) kapsam\u0131ndaki uzmanlar\u0131n katk\u0131lar\u0131yla haz\u0131rland\u0131\u011f\u0131 bildirildi. \u00c7al\u0131\u015fma kapsam\u0131nda 2024 y\u0131l\u0131n\u0131n Aral\u0131k ay\u0131nda uzman g\u00f6r\u00fc\u015fmesi ger\u00e7ekle\u015ftirildi\u011fi, 2025 bahar\u0131nda ise sekt\u00f6r uzmanlar\u0131, \u00fcr\u00fcn geli\u015ftiriciler, bilim insanlar\u0131, \u00e7ocuk onkologlar\u0131, eczac\u0131lar, form\u00fclasyon uzmanlar\u0131 ve sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131ndan g\u00f6r\u00fc\u015f al\u0131nd\u0131\u011f\u0131 belirtildi.<\/p>\n
DS\u00d6, yeni form\u00fclasyonlarda \u00e7\u00f6z\u00fcn\u00fcr veya a\u011f\u0131zda da\u011f\u0131lan tabletler, mini tabletler ve \u00e7ok par\u00e7ac\u0131kl\u0131 dozaj formlar\u0131 gibi \u00e7ocuklar\u0131n kullan\u0131m\u0131na uygun se\u00e7eneklerin \u00f6nceliklendirilmesini \u00f6nerdi. Ayr\u0131ca s\u0131cak ve nemli iklimlere uygun, 24 aydan uzun raf \u00f6mr\u00fcne sahip stabil form\u00fclasyonlar, kabul edilebilir tat profilleri, d\u00fc\u015f\u00fck okuryazarl\u0131k d\u00fczeyine sahip bak\u0131m verenler i\u00e7in anla\u015f\u0131l\u0131r kullan\u0131m talimatlar\u0131 ve d\u00fc\u015f\u00fck ve orta gelirli \u00fclkelerde eri\u015filebilirli\u011fi destekleyecek uygun maliyetli ve s\u00fcrd\u00fcr\u00fclebilir \u00fcretim \u00f6ne \u00e7\u0131kan kriterler aras\u0131nda yer ald\u0131.<\/p>\n
DS\u00d6 Bilim B\u00f6l\u00fcm\u00fc b\u00fcnyesindeki GAP-f lideri Martina Penazzato, \u201cHer \u00e7ocuk, g\u00fcvenli, etkili ve ya\u015f\u0131na uygun ila\u00e7lar\u0131 hak ediyor.\u201d ifadelerini kullanarak, \u00e7ocukluk \u00e7a\u011f\u0131 kanser ila\u00e7lar\u0131n\u0131n geli\u015ftirilmesi i\u00e7in yat\u0131r\u0131m ve yenili\u011fe ihtiya\u00e7 bulundu\u011funu belirtti.<\/p>\n
DS\u00d6, yay\u0131mlanan alt\u0131 hedef \u00fcr\u00fcn profilinin, s\u00f6z konusu form\u00fclasyonlar\u0131n geli\u015ftirilmesinin ard\u0131ndan gelecekte DS\u00d6 \u00d6n Yeterlilik Program\u0131 kapsam\u0131nda de\u011ferlendirilmesine ve daha sonra \u00c7ocuklar \u0130\u00e7in Temel \u0130la\u00e7lar Model Listesi\u2019ne dahil edilmesine temel olu\u015fturabilece\u011fini bildirdi.<\/p>\n
<\/strong> Cenevre, 20 Eyl\u00fcl (Hibya)-D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6), \u00e7ocuklarda kullan\u0131ma uygun kanser ila\u00e7lar\u0131n\u0131n geli\u015ftirilmesi amac\u0131yla alt\u0131 yeni hedef \u00fcr\u00fcn profili yay\u0131mlad\u0131. Profiller, ila\u00e7 \u00fcreticilerine \u00e7ocuklara y\u00f6nelik daha g\u00fcvenli, etkili ve kullan\u0131m\u0131 kolay form\u00fclasyonlar\u0131n geli\u015ftirilmesi i\u00e7in teknik bir yol haritas\u0131 sunuyor.<\/p>\n","protected":false},"author":1,"featured_media":152896,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAow07ekDA:productID":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-152895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dunya"],"_links":{"self":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/152895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=152895"}],"version-history":[{"count":0,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/152895\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/media\/152896"}],"wp:attachment":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=152895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=152895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=152895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nEKONOM\u0130 GAZETES\u0130 <\/p>\n","protected":false},"excerpt":{"rendered":"